CAREDX INC (CDNA) Forecast, Price Target & Analyst Ratings
NASDAQ:CDNA • US14167L1035
17.15 USD
+0.17 (+1%)
At close: Mar 11, 2026
17.15 USD
0 (0%)
Pre-Market: 3/12/2026, 4:08:37 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CAREDX INC (CDNA).
Forecast Snapshot
Consensus Price Target
$24.48
+ 42.74% Upside
Next Earnings Forecast
Release DateApr 28, 2026
PeriodQ1 / 2026
EPS Estimate$0.15
Revenue Estimate103.93M
ChartMill Buy Consensus
78.67%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$24.48
Upside
+ 42.74%
From current price of $17.15 to mean target of $24.48, Based on 15 analyst forecasts
Low
$18.18
Median
$26.01
High
$29.40
Price Target Revisions
1 Month
3.45%
3 Months
4.35%
Price Target Summary
15 Wall Street analysts provided a forecast for the next 12 months for CDNA. The average price target is 24.48 USD. This implies a price increase of 42.74% is expected in the next year compared to the current price of 17.15.
The average price target has been revised upward by 4.35% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
78.67%
CDNA was analyzed by 15 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about CDNA.
In the previous month the buy percentage consensus was at a similar level.
CDNA was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-26 | BTIG | Maintains | Buy -> Buy |
| 2026-02-25 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-15 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-06 | BTIG | Maintains | Buy -> Buy |
| 2025-09-23 | BTIG | Reiterate | Buy -> Buy |
| 2025-09-12 | BTIG | Reiterate | Buy -> Buy |
| 2025-08-26 | William Blair | Initiate | Market Perform |
| 2025-08-08 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-18 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-05-05 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2025-05-05 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-04-17 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-02-27 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2025-01-15 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-05 | BTIG | Maintains | Buy -> Buy |
| 2024-10-22 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-10-16 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-08-27 | Wells Fargo | Initiate | Underweight |
| 2024-08-19 | BTIG | Upgrade | Neutral -> Buy |
| 2024-08-01 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-08-01 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-07-17 | Goldman Sachs | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 28, 2026
PeriodQ1 / 2026
EPS Estimate$0.15
Revenue Estimate103.93M
Revenue Q2Q22.73%
EPS Q2Q71.78%
Number of Analysts11
Next Earnings Revisions
Revenue (1 Month)
1.47%
Revenue (3 Months)
1.33%
EPS (1 Month)
-29.13%
EPS (3 Months)
-28.17%
Next Earnings Summary
CDNA is expected to report earnings on 4/28/2026. The consensus EPS estimate for the next earnings is 0.15 USD and the consensus revenue estimate is 103.93M USD.
The next earnings revenue estimate has been revised upward by 1.33% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 280.324M -12.89% | 333.785M 19.07% | 379.805M 13.79% | 438.18M 15.37% | 487.38M 11.23% | 538.95M 10.58% | |
| EBITDA YoY % growth | -89.657M -36.67% | -39.558M 55.88% | -10.053M 74.59% | 39.974M 497.63% | 62.386M 56.07% | 84.221M 35.00% | |
| EBIT YoY % growth | -104.043M -34.77% | -53.752M 48.34% | -25.071M 53.36% | 35.748M 242.59% | 49.374M 38.12% | 56.757M 14.95% | |
| Operating Margin | -37.12% | -16.10% | -6.60% | 8.16% | 10.13% | 10.53% | |
| EPS YoY % growth | -0.64 -64.10% | 0.54 184.38% | 0.59 9.26% | 0.73 24.55% | 1.15 56.14% | 1.65 44.23% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.15 71.78% | 0.19 92.78% | 0.23 -18.19% | 0.23 89.43% | 0.20 31.95% | 0.26 32.28% | 0.30 29.14% | 0.35 52.56% |
| Revenue Q2Q % growth | 103.93M 22.73% | 108.31M 24.96% | 107.2M 7.14% | 109.83M 1.33% | 107.67M 3.60% | 113.99M 5.24% | 115.94M 8.15% | 121.73M 10.83% |
| EBITDA Q2Q % growth | 8.322M 288.54% | 9.956M 388.66% | 12.731M -3.48% | 12.863M 43.27% | 12.918M 55.23% | 16.289M 63.61% | 19.532M 53.42% | 23.397M 81.89% |
| EBIT Q2Q % growth | 2.702M 133.72% | 5.117M 147.51% | 6.3M 206.72% | 7.002M 215.93% | 1.966M -27.24% | 6.444M 25.93% | 9.141M 45.10% | 12.853M 83.56% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
41.02%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
12.14%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
43.44%
EBIT Next 5 Year
N/A
CAREDX INC / CDNA Forecast FAQ
What is the price target for CDNA stock?
15 analysts have analysed CDNA and the average price target is 24.48 USD. This implies a price increase of 42.74% is expected in the next year compared to the current price of 17.15.
When does CAREDX INC (CDNA) report earnings?
CAREDX INC (CDNA) will report earnings on 2026-04-28, after the market close.
What are the consensus estimates for CDNA stock next earnings?
The consensus EPS estimate for the next earnings of CAREDX INC (CDNA) is 0.15 USD and the consensus revenue estimate is 103.93M USD.
What is the expected long term growth rate for CAREDX INC (CDNA)?
The expected long term growth rate for CAREDX INC (CDNA) is 12.14%.